You just read:

Janssen Submits New Drug Application to U.S. FDA for Simeprevir (TMC435) for Combination Treatment of Adult Patients with Genotype 1 Chronic Hepatitis C

News provided by

Janssen Research & Development, LLC

Mar 28, 2013, 05:00 ET